AMAG Pharma (AMAG) Tops Q1 EPS by 29c; Boosts FY15 Revenue Outlook

Go back to AMAG Pharma (AMAG) Tops Q1 EPS by 29c; Boosts FY15 Revenue Outlook

AMAG Pharmaceuticals Reports Record First Quarter 2015 Financial Results and Increases Financial Guidance

May 5, 2015 7:00 AM EDT

First Quarter 2015 net product sales of $77.4 million and adjusted EBITDA of $47.4 million Company increases top and bottom line 2015 financial guidance

Conference call scheduled for 8:00 a.m. ET today

WALTHAM, Mass., May 5, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG), a specialty pharmaceutical company, today reported unaudited consolidated financial results for the first quarter of 2015. Total revenues for the first quarter of 2015 increased to $89.5 million, compared with $20.8 million in the first quarter of 2014. This increase was primarily due to the addition... More

AMAG Pharmaceuticals Reports Record First Quarter 2015 Financial Results and Increases Financial Guidance

May 5, 2015 7:00 AM EDT

First Quarter 2015 net product sales of $77.4 million and adjusted EBITDA of $47.4 million Company increases top and bottom line 2015 financial guidance

Conference call scheduled for 8:00 a.m. ET today

WALTHAM, Mass., May 5, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG), a specialty pharmaceutical company, today reported unaudited consolidated financial results for the first quarter of 2015. Total revenues for the first quarter of 2015 increased to $89.5 million, compared with $20.8 million in the first quarter of 2014. This increase was primarily due to the addition... More